Citizens National Bank Trust Department’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
MIH
MSR
PR
SO
WT
Citizens National Bank Trust Department's XBI Position: Q2 2026 in Review
Citizens National Bank Trust Department held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 776 shares worth $123K. The position accounts for 0.02% of the portfolio, ranked #210.
Citizens National Bank Trust Department first reported a position in XBI in Q4 2025 and has held it in 3 quarters since. 551 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Citizens National Bank Trust Department held 776 shares of State Street SPDR S&P Biotech ETF worth $123K as of Q2 2026.
- Citizens National Bank Trust Department left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
- State Street SPDR S&P Biotech ETF made up 0.02% of Citizens National Bank Trust Department's portfolio in Q2 2026, its #210 holding.
- Citizens National Bank Trust Department first reported a position in State Street SPDR S&P Biotech ETF in Q4 2025 and has held it in 3 quarters since.
- 551 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Citizens National Bank Trust Department's 13F filing for Q2 2026, filed 22 Jul 2026.